Sandhu Sumandeep K, Ross Linda S, Gill Sarjeet S
Environmental Toxicology Graduate Program and Department of Cell Biology and Neuroscience, University of California, Riverside 92521, USA.
Eur J Biochem. 2002 Aug;269(16):3934-44. doi: 10.1046/j.1432-1033.2002.03084.x.
Serotonin transporters are key target sites for clinical drugs and psychostimulants, such as fluoxetine and cocaine. Molecular cloning of a serotonin transporter from the central nervous system of the insect Manduca sexta enabled us to define domains that affect antagonist action, particularly cocaine. This insect serotonin transporter transiently expressed in CV-1 monkey kidney cells exhibits saturable, high affinity Na+ and Cl- dependent serotonin uptake, with estimated Km and Vmax values of 436 +/- 19 nm and 3.8 +/- 0.6 x 10-18 mol.cell.min-1, respectively. The Manduca high affinity Na+/Cl- dependent transporter shares 53% and 74% amino acid identity with the human and fruit fly serotonin transporters, respectively. However, in contrast to serotonin transporters from these two latter species, the Manduca transporter is inhibited poorly by fluoxetine (IC50 = 1.23 micro m) and cocaine (IC50 = 12.89 micro m). To delineate domains and residues that could play a role in cocaine interaction, the human serotonin transporter was mutated to incorporate unique amino acid substitutions, detected in the Manduca homologue. We identified a domain in extracellular loop 2 (amino acids 148-152), which, when inserted into the human transporter, results in decreased cocaine sensitivity of the latter (IC50 = 1.54 micro m). We also constructed a number of chimeras between the human and Manduca serotonin transporters (hSERT and MasSERT, respectively). The chimera, hSERT1-146/MasSERT106-587, which involved N-terminal swaps including transmembrane domains (TMDs) 1 and 2, was remarkably insensitive to cocaine (IC50 = 180 micro m) compared to the human (IC50 = 0.431 micro m) and Manduca serotonin transporters. The chimera MasSERT1-67/hSERT109-630, which involved only the TMD1 swap, showed greater sensitivity to cocaine (IC50 = 0.225 micro m) than the human transporter. Both chimeras showed twofold higher serotonin transport affinity compared to human and Manduca serotonin transporters. Our results show TMD1 and TMD2 affect the apparent substrate transport and antagonist sensitivity by possibly providing unique conformations to the transporter. The availability of these chimeras facilitates elucidation of specific amino acids involved in interactions with cocaine.
血清素转运体是临床药物和精神兴奋剂(如氟西汀和可卡因)的关键靶点。从烟草天蛾中枢神经系统克隆得到的血清素转运体,使我们能够确定影响拮抗剂作用的结构域,尤其是可卡因的作用结构域。这种在CV-1猴肾细胞中瞬时表达的昆虫血清素转运体表现出可饱和的、高亲和力的、依赖Na⁺和Cl⁻的血清素摄取,估计Km和Vmax值分别为436±19 nM和3.8±0.6×10⁻¹⁸ mol·细胞·分钟⁻¹。烟草天蛾高亲和力的依赖Na⁺/Cl⁻的转运体与人类和果蝇的血清素转运体分别具有53%和74%的氨基酸同一性。然而,与后两种物种的血清素转运体不同,烟草天蛾转运体对氟西汀(IC50 = 1.23 μM)和可卡因(IC50 = 12.89 μM)的抑制作用较弱。为了确定在可卡因相互作用中可能起作用的结构域和残基,将人类血清素转运体进行突变,使其包含在烟草天蛾同源物中检测到的独特氨基酸取代。我们在细胞外环2(氨基酸148 - 152)中鉴定出一个结构域,当将其插入人类转运体时,会导致后者对可卡因的敏感性降低(IC50 = 1.54 μM)。我们还构建了一些人类和烟草天蛾血清素转运体(分别为hSERT和MasSERT)之间的嵌合体。涉及包括跨膜结构域(TMDs)1和2的N端交换的嵌合体hSERT1 - 146/MasSERT106 - 587,与人类(IC50 = 0.431 μM)和烟草天蛾血清素转运体相比,对可卡因的敏感性显著降低(IC50 = 180 μM)。仅涉及TMD1交换的嵌合体MasSERT1 - 67/hSERT109 - 630,对可卡因的敏感性(IC50 = 0.225 μM)高于人类转运体。与人类和烟草天蛾血清素转运体相比,这两种嵌合体的血清素转运亲和力都高出两倍。我们的结果表明,TMD1和TMD2可能通过为转运体提供独特的构象来影响表观底物转运和拮抗剂敏感性。这些嵌合体的可用性有助于阐明与可卡因相互作用中涉及的特定氨基酸。